Composition for hangover relief and liver function improvement, comprising raw powder material, and preparation method therefor
Patent Information
- Application Number
- PCT/KR2023/018684
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-08-31
- Filing Date
- 2023-11-20
- Publication Date
- 2024-11-07
AI Technical Summary
Conventional hangover relievers are not effective in alleviating acute hangover symptoms and may cause gastrointestinal discomfort, while existing functional drinks containing herbal medicines can be burdensome to the body and have unclear safety profiles.
A composition comprising L-ornithine, potassium citrate, cabbage powder, and lactic acid bacteria (Bifidobacteria and Lactobacillus) is developed to suppress alcohol absorption, promote metabolism, and reduce inflammatory responses, thereby relieving hangover symptoms and improving liver function.
The composition effectively reduces hangover severity and improves liver function by inhibiting alcohol absorption, enhancing metabolism, and minimizing systemic effects, while being gentle on the body.
Smart Images

Figure 000001 
Figure 000002 
Figure 000003
Abstract
Description
Composition for relieving hangover and improving liver function containing powdered raw materials and method for producing the same
[0001] The examples below relate to a composition for relieving hangovers and improving liver function, including powdered raw materials, and a method for producing the same.
[0002] About 10% of the ethanol absorbed through drinking is excreted from the body through breath or urine, and the remaining 90% is metabolized in the digestive system or liver. Alcohol metabolism occurs in the liver, where alcohol dehydrogenase (ADH) oxidizes ethanol to acetaldehyde, which is then oxidized to acetaldehyde by aldehyde dehydrogenase (ALDH) into acetic acid. Both of these oxidation processes require NAD (Nicotinamide Adenine dinucleotide). The resulting acetic acid is converted into carbon dioxide and water by acetyl coenzyme A, with the carbon dioxide being excreted through the lungs and the water being excreted through urine and other organs. Excessive alcohol consumption causes hangovers, and hangovers are known to cause alcohol and acetaldehyde to accumulate in the body, acting as major toxic substances in each organ, causing negative effects on the body such as headaches, fatigue, sensitivity to light and sound, muscle pain, bloodshot eyes, thirst, nausea, vomiting, and stomachache.
[0003] To relieve hangovers, many functional beverages or compositions, including those containing ingredients extracted from natural ingredients, have been developed, as described in Korean Patent No. 10-0853078. These functional beverages are consumed alone after drinking or added to high-alcohol beverages before drinking. However, their hangover relief effects are still not that significant. Furthermore, some drinks containing herbal medicines can cause abdominal bloating and abdominal pain, raising questions about their harmful effects on the human body. Therefore, there is a need to develop compositions that are both gentle on the body and effective in relieving hangovers.
[0004] [Prior Art Literature]
[0005] [Patent Document]
[0006] (Patent Document 1) Republic of Korea Patent Publication No. 10-0853078
[0007] The examples below are designed to solve the above problems, and the purpose of the present invention is to provide a composition that is less burdensome to the human body while at the same time exhibiting a sufficient hangover relief effect, and a method for producing the same.
[0008] In order to achieve the above-described object of the present invention, one embodiment of the present invention provides a food composition for relieving hangover and improving liver function, comprising L-ornithine, potassium citrate, cabbage powder, and one or more lactic acid bacteria selected from the group consisting of bifidobacteria and lactobacillus, and a method for producing the same.
[0009] One embodiment of the present invention provides a method for producing a food composition for relieving hangovers and improving liver function, comprising the steps of: extracting and drying cabbage to produce cabbage powder; and mixing L-ornithine, potassium citrate, and one or more lactic acid bacteria selected from the group consisting of bifidobacteria and lactobacillus with the cabbage powder.
[0010] The present invention has the advantage of being both less burdensome on the human body and simultaneously providing a sufficient hangover relief effect. Accordingly, embodiments of the present invention provide hangover relief and improved liver function.
[0011] Hereinafter, embodiments are described in detail with reference to the attached drawings. However, the embodiments may be modified in various ways, and the scope of the patent application is not limited or restricted by these embodiments. It should be understood that all modifications, equivalents, or alternatives to the embodiments are included within the scope of the patent application.
[0012] Specific structural or functional descriptions of the embodiments are disclosed for illustrative purposes only and may be modified and implemented in various forms. Accordingly, the embodiments are not limited to the specific disclosed form, and the scope of this specification includes modifications, equivalents, or alternatives that fall within the technical concept.
[0013] Although terms such as "first" or "second" may be used to describe various components, these terms should be interpreted solely to distinguish one component from another. For example, a first component may be referred to as a second component, and similarly, a second component may also be referred to as a first component.
[0014] When it is said that a component is “connected” to another component, it should be understood that it may be directly connected or connected to that other component, but there may also be other components in between.
[0015] The terms used in the examples are for the purpose of description only and should not be construed as limiting. The singular expression includes the plural expression unless the context clearly indicates otherwise. In this specification, the terms “comprise” or “have” should be understood to indicate the presence of a feature, number, step, operation, component, part, or combination thereof described in the specification, but do not exclude in advance the possibility of the presence or addition of one or more other features, numbers, steps, operations, components, parts, or combinations thereof.
[0016] Unless otherwise defined, all terms used herein, including technical or scientific terms, have the same meaning as commonly understood by a person of ordinary skill in the art to which the embodiments pertain. Terms defined in commonly used dictionaries should be interpreted as having a meaning consistent with their meaning in the context of the relevant technology, and shall not be interpreted in an idealized or overly formal sense unless explicitly defined herein.
[0017] The advantages and features of the present invention, and the methods for achieving them, will become clearer with reference to the embodiments described in detail below together with the accompanying drawings. However, the present invention is not limited to the embodiments disclosed below, but may be implemented in various different forms. These embodiments are provided solely to ensure that the disclosure of the present invention is complete and to fully inform those skilled in the art of the scope of the invention, and the present invention is defined solely by the scope of the claims.
[0018] In the embodiments of the present invention, unless otherwise defined, all terms, including technical or scientific terms, used herein have the same meaning as commonly understood by those of ordinary skill in the art to which the present invention pertains. Terms defined in commonly used dictionaries should be interpreted as having a meaning consistent with their meaning in the context of the relevant technology, and shall not be interpreted in an idealized or overly formal sense unless explicitly defined in the embodiments of the present invention.
[0019] The shapes, sizes, ratios, angles, numbers, etc. disclosed in the drawings for explaining embodiments of the present invention are exemplary, and therefore the present invention is not limited to the matters illustrated. In addition, in describing the present invention, if it is determined that a detailed description of a related known technology may unnecessarily obscure the gist of the present invention, the detailed description thereof will be omitted. When the terms “includes,” “has,” and “consists of” are used in this specification, other parts may be added unless “only” is used. When a component is expressed in the singular, it includes a case where the plural is included unless there is a specifically explicit description.
[0020] When interpreting a component, it is interpreted as including the error range even if there is no separate explicit description.
[0021] The size and thickness of each component shown in the drawing are shown for convenience of explanation, and the present invention is not necessarily limited to the size and thickness of the component shown.
[0022] The individual features of the various embodiments of the present invention can be partially or wholly combined or combined with each other, and as can be fully understood by those skilled in the art, various technical connections and operations are possible, and each embodiment can be implemented independently of each other or can be implemented together in a related relationship.
[0023] Hereinafter, the present invention will be described in detail with reference to examples and drawings. However, it is obvious that the present invention is not limited to the following examples and drawings.
[0024] Hangover relief and improved liver function
[0025] Conventional hangover remedies are primarily composed of substances that aid liver metabolism. However, substances that address chronic reactions caused by drinking often have less dramatic effects in the acute phase and have limited effectiveness. Therefore, the inventors of the present invention analyzed the acute phase reactions of the liver, gastrointestinal tract, and blood that occur during heavy drinking, and determined that it was necessary to eliminate the main factors that cause hangovers from a medical perspective. Therefore, they completed the present invention with the goal of minimizing the effects of alcohol absorption in the gastrointestinal tract, liver, and blood. More specifically, in the process of absorption inhibition, metabolism (decomposition) promotion, minimization of systemic symptoms, and excretion promotion, the present invention was completed with the goals of 1) enhancing alcohol decomposition in the gastrointestinal tract, 2) inhibiting alcohol absorption in the gastrointestinal tract, 3) increasing the efficiency of alcohol metabolism in the liver and suppressing hangover-inducing substances, and 4) minimizing the systemic effects of alcohol in the blood.
[0026] About 10% of ethanol (officially ethyl alcohol) absorbed through drinking is excreted through breath or urine. Of the remaining 90%, 20% is absorbed in the stomach and 80% in the small intestine. Alcohol absorbed through the gastrointestinal mucosa does not require special receptors and is rapidly absorbed into the liver through the bloodstream. It mixes with blood in the portal vein and hepatic arterioles, is exposed to hepatocytes, undergoes metabolism, and is then absorbed into the central artery. Alcohol that passes through this pathway is oxidized in the liver cells and converted to non-toxic acetate, which is used as energy (1 gram of alcohol equals approximately 7.1 kcal). Because liver cell metabolism is limited in speed, any unmetabolized alcohol enters the bloodstream, leading to an increase in blood alcohol concentration. Unoxidized excess alcohol enters the bloodstream, circulates throughout the body, and is then metabolized in the liver. Consequently, excessive drinking can lead to a high blood alcohol concentration. Alcohol easily passes through cell membranes and mixes well with cell lipid membranes, disrupting normal cellular signaling. Furthermore, alcohol spreads to various organs through the systemic circulation, manifesting as systemic symptoms. Over 90% of absorbed alcohol is metabolized to acetaldehyde in the liver, which processes alcohol at a rate of approximately one drink per hour.
[0027] The primary metabolic process of alcohol metabolism is largely divided into 1) alcohol dehydrogenase (ADH) system, 2) microsomal ethanol oxidizing system (MEOS), and 3) catalase system. Among these, the clinically important pathways are 1) and 2). Pathway 1) is the main pathway for alcohol decomposition, and corresponds to the pathway in which alcohol is oxidized to acetaldehyde by the ADH enzyme present in the cytoplasm of hepatocytes. The intermediate substance, acetaldehyde, is a highly unstable and toxic substance and is one of the main causes of liver damage (causing hangover symptoms such as facial flushing, tachycardia, headache, and vomiting). The acetaldehyde is rapidly converted to acetic acid by acetaldehyde dehydrogenase (ALDH) present in the mitochondria (secondary metabolic process). Acetaldehyde metabolism within mitochondria occurs rapidly, but it is slow in many Asians with ALDH mutations, which leads to acetaldehyde accumulation and is considered a major factor in hangovers. When acetaldehyde concentration increases, various hangover symptoms and inflammatory reactions occur. Pathway 2) above accounts for 10-20% of alcohol metabolism and is the pathway for metabolizing various drugs. Pathway 2) above occurs when alcohol metabolism through the ADH pathway is insufficient due to excessive drinking, and ethanol is oxidized to acetaldehyde. As drinking is repeated over a long period of time, the enzyme ability increases 5-10 times, making you feel like you have increased your alcohol tolerance. More specifically, two electrons from NADPH are transferred to CYP2E1 (Cytochrome P450), a membrane protein located in the membrane of the hepatocyte endoplasmic reticulum, and ethanol binds to CYP2E1 and is oxidized to acetaldehyde. During this process, reactive oxygen species (ROS) are generated.The above ROS is converted into hydrogen peroxide (H2O2) and attacks the cell membrane (lipid), inhibiting the electron transport chain and oxidative phosphorylation process. As a result, cells undergo an inflammatory response and die, and long-term exposure to ROS can cause diseases such as liver cirrhosis. In the secondary metabolic process of alcohol metabolism, if the intermediate substance acetaldehyde accumulates in large quantities, it cannot be converted to acetic acid at a certain speed, so it enters the blood through diffusion and causes systemic symptoms (hangover symptoms such as vomiting, flushing, and nausea). Acetaldehyde is metabolized into the final oxide, acetate, through ALDH in the mitochondria.
[0028] In the primary / secondary metabolic process, the reduced product NADH increases, resulting in NADH / NAD + The ratio increases. The increase in NADH causes metabolic disorder. In the normal aerobic metabolic process, carbohydrates / fat / protein are metabolized in the TCA cycle to produce NADH, which is converted into ATP to produce energy. When NADH increases due to drinking, the normal aerobic metabolic process is suppressed in the opposite way. Since there is sufficient NADH, the metabolic process (glycolysis / gluconeogenesis / TCA cycle (energy production) / fatty acid oxidation) proceeds in the direction of suppressing energy production. Therefore, energy production is suppressed and hypoglycemia occurs. As a result of alcohol metabolism, acetic acid accumulates, causing fat accumulation, and lactic acid is generated, accumulating fatigue. Fasting blood sugar levels drop or remain lower than usual, and postprandial blood sugar levels rise.
[0029] Furthermore, alcohol consumption causes diuresis, leading to potassium depletion, which in turn impairs the cellular response to ROS and exacerbates the decline in ATP production. Potassium depletion is exacerbated by alcohol, which interferes with the secretion of antidiuretic hormone (ADH) produced by the posterior pituitary gland and worsens hyponatremia. For example, potassium loss stimulates ADH activity, increasing the amount of fluid reabsorbed and consequently decreasing sodium concentration in the body. Furthermore, potassium loss can increase thirst through hormonal mechanisms, leading to increased water intake. When extracellular fluid (ECF) potassium is depleted, the concentration gradient causes potassium to shift from the intracellular fluid (ICF) to the ECF. This decreases cytoplasmic potassium. Meanwhile, although the inner mitochondrial membrane is not very permeable to cations, a certain amount of potassium flows into the mitochondrial matrix, depending on the concentration gradient. The influx of potassium maintains the volume of mitochondria, keeping the membrane taut and maintaining the electrical potential difference. When the potassium in the cytoplasm decreases, K moves toward the mitochondrial matrix. + This decrease in outflow results in a potassium deficiency in the mitochondria. This tends to lead to a decline in overall mitochondrial function, including energy production. This situation, in which ATP synthesis is poor and cellular respiration is sluggish, creates conditions that facilitate the formation of ROS. NADH / NAD +In a highly hyperreduced state, excess electrons are easily transferred to and combined with oxygen, which increases the probability of generating ROS. In addition, a large amount of ROS is also generated during the alcohol breakdown process through the microsomal ethanol oxidizing system (MEOS) due to excessive drinking. ROS is the cause of inflammation, aging, cancer, and degenerative diseases. Under stress conditions where ROS is generated, mitochondria activate ATP-dependent potassium channels to inflow potassium into the mitochondrial matrix. This lowers the membrane potential difference and reduces superoxide anion production, thereby suppressing ROS production. Therefore, maintaining cytosolic potassium concentration can be expected to suppress ROS production, thereby suppressing inflammatory responses and normalizing mitochondrial function. Since ALDH decomposes acetaldehyde within the mitochondria, this can also be expected to be activated. It is expected that potassium supplementation will suppress both the inflammatory response and acetaldehyde production, which are identified as the main causes of hangovers.
[0030] Accordingly, the present inventors have discovered that the direct cause of hangover lies in blood cytokines rather than alcohol and acetaldehyde, considering that 1) blood ethanol concentration reaches its maximum 60 to 90 minutes after drinking and decreases over time, 2) blood acetaldehyde reaches its maximum concentration within 1 hour after drinking, and 3) hangover is at its maximum 12 to 14 hours after drinking (at this time, alcohol and acetaldehyde are almost completely metabolized). In particular, the present inventors have discovered that the time of cytokine expression after alcohol stimulation coincides with the time of hangover expression, and that when cytokines are injected into healthy people, hangover-like symptoms such as gastrointestinal disorder, headache, chills, fatigue, and vomiting occur. Accordingly, the present inventors have hypothesized that the main factor of hangover is a decrease in cellular immunity mediated by IL-10 and 12 (IL-10, IL-12).
[0031] Fatigue recovery
[0032] In one aspect, the present invention provides a food composition for fatigue recovery. Ammonia is a good indicator of fatigue during exercise. The central fatigue mechanism of ammonia is that when a large amount of toxic ammonia accumulates, motor function is impaired, such as lethargy, convulsions, ataxia, and coma. The peripheral fatigue mechanism is that ammonia accumulation in muscles can stimulate afferent nerves related to muscle pain perception, thereby causing fatigue. The composition according to the present invention can reduce the concentrations of ammonia, cortisol, and lactic acid, which are fatigue substances in the blood, and rapidly increase the concentration of hydrogen ions (pH), and thus can be effective in rapidly alleviating fatigue after exercise.
[0033] Food composition for relieving hangovers and improving liver function
[0034] In one aspect, the present invention provides a food composition for relieving hangovers and improving liver function, comprising L-ornithine, potassium citrate, cabbage powder, and one or more lactic acid bacteria selected from the group consisting of bifidobacteria and lactobacillus.
[0035] In particular, the inventors of the present invention have discovered that when the above ingredients are included as active ingredients in a composition, they exert a sufficient hangover-relieving effect while minimizing the burden on the human body. They have thus completed the present invention, and have discovered a method of approaching hangover relief from a medical perspective by applying safe substances approved for food use. The composition of the present invention can be utilized for hangover relief and improved liver function.
[0036] In the present invention, the term “extract” means an active ingredient separated from a natural product, and can be obtained by an extraction process using water, an organic solvent, or a mixed solvent thereof, and includes an extract, a dried powder thereof, or all forms formulated using the same. The extracted liquid can be used directly, or can be used as a “powder” after being concentrated and / or dried. When extracting using an organic solvent, an organic solvent such as methanol, ethanol, isopropanol, butanol, ethylene, acetone, hexane, ether, chloroform, ethyl acetate, butyl acetate, dichloromethane, N,N-dimethylformamide (DMF), dimethyl sulfoxide (DMSO), 1,3-butylene glycol, propylene glycol, or a mixed solvent thereof is used, and the extraction can be performed at room temperature or at a temperature where the active ingredient is not destroyed or is minimized. The degree of extraction and loss of active ingredients in medicinal herbs can vary depending on the organic solvent used. Therefore, it is important to select and use an appropriate organic solvent. Extraction methods are not particularly limited, and include hot water extraction, cold infusion extraction, ultrasonic extraction, and reflux extraction.
[0037] The above solvent extract may further include a step of filtering the extract to remove floating solid particles. The particles may be filtered using cotton, nylon, etc., or ultrafiltration, cryofiltration, centrifugation, etc. may be used, but are not limited thereto. When concentrating the extract, methods such as reduced pressure concentration and reverse osmosis concentration may be used. The drying step after concentration includes, but is not limited to, freeze drying, vacuum drying, hot air drying, spray drying, reduced pressure drying, foam drying, high-frequency drying, and infrared drying.
[0038] According to the composition of the present invention, 1) alcohol absorption is inhibited, 2) the decomposition of alcohol and its by-products is activated, and 3) inflammatory reactions caused by alcohol and its by-products are suppressed. More specifically, the composition of the present invention exhibits the effect of inhibiting absorption in the gastrointestinal tract, promoting decomposition in the liver, suppressing the production of inflammatory substances, and maintaining optimal liver function to facilitate metabolism when excessive alcohol is consumed. Since the composition of the present invention is taken with or immediately after drinking, it is particularly excellent for short-term effects that address symptoms occurring in the acute phase.
[0039] The inventor named the composition of the present invention, which has hangover relief and liver function effects, 'Morning WOW'.
[0040]
[0041] *The above “active ingredient” refers to an ingredient that exhibits the desired activity or an ingredient that can exhibit activity together with a carrier that is inactive in itself.
[0042] The above "L-ornithine" is a basic amino acid that plays an important role as an intermediate in the urea cycle. In the urea cycle, L-ornithine enters the mitochondria from the cytoplasm, where it captures an ammonia group to synthesize L-citrulline, which is then released into the cytoplasm to become arginosuccinate. This removes nitrogen groups from the mitochondria. Then, arginosuccinate receives the second amino group of urea from aspartate, and the carbon group of aspartate is removed to fumarate, and the nitrogen group is transferred to arginine, synthesizing harmless urea. Urea is then excreted through the kidneys. The two major cycles that operate in the body are the citric acid cycle (TCA cycle), which produces energy, and the urea cycle, which processes ammonia. The citric acid cycle occurs within the mitochondria, while the urea cycle spans the cytoplasm and mitochondria. The two cycles interact by sharing intermediate metabolites (argininosuccinate shunt) and utilizing a portion of the ATP (4 ATP) generated in the citric acid cycle. Amino acids produce ammonia (a nitrogen compound), a toxic metabolite, as a byproduct. This is converted to harmless urea through the urea cycle and excreted through the kidneys.
[0043] Under drinking conditions, alcohol breakdown by ADH takes precedence over mitochondrial metabolism of other nutrients, resulting in the accumulation of NADH and NADH / NAD + The ratio increases. This is why NAD +The TCA cycle, which converts oxaloacetate into NADH, is slowed down. Oxaloacetate in the TCA cycle receives the amino group of glutamate to become aspartate, which then transfers the amino group to the urea cycle via arginosuccinate. However, in the case of drinking, NADH / NAD + Aspartic acid is metabolized to oxaloacetate, which lowers NADH levels. As a result, the amino group of aspartic acid is not transferred to the urea cycle, but is transferred to alpha-glutarate to produce glutamate. This reduces amino group removal in hepatocytes, and it is expected that ammonium ions will accumulate, which will lead to mitochondrial dysfunction. The present invention supplemented ornithine, which enters the mitochondria and captures nitrogen groups.
[0044] The above L-ornithine directly enters the mitochondria, captures nitrogen from ammonia, converts it into citrulline, and excretes it outside the mitochondria. In other words, it plays a role in removing it into the cytoplasm. In a situation where ammonia removal is reduced due to an increase in blood alcohol concentration, the above L-ornithine has a direct effect on ammonia removal. In addition, it is expected to maximize the nitrogen group removal effect with ornithine by supplying carbon dioxide required for carbamoyl phosphate, which is produced in the process of transferring ammonium to ornithine, into the mitochondria. The present invention focuses on normalizing mitochondria by preventing the accumulation of amino groups in the mitochondria. To this end, potassium citrate was supplemented to replenish carbon dioxide whose production was slowed due to a slowdown in the TCA cycle. As ammonia inside the mitochondria is effectively removed, acetaldehyde decomposition in the mitochondria is normalized, leading to a decrease in ROS generation, creating a virtuous cycle, normalizing the mitochondria, and ultimately, the effect of acetaldehyde decomposition in ALDH inside the mitochondria is exerted.
[0045] The above “potassium citrate” is an alkaline organic salt compound and acts as an alkalizing agent. Potassium citrate has a buffering effect on gastric acidity, which is thought to be due to chloride ions before absorption and bicarbonate after absorption. The above potassium citrate is 90% ionized at physiological pH, and the ionized citric acid acts as a trivalent anion. In our body, bicarbonate ions (HCO3) in the blood - ) and hydrogen ions (H + ) are converted into water and carbon dioxide and form an equilibrium (HCO3 - + H + <-> H2O + CO2). Citric acid released in the blood is H + Combined with HCO3 - It has the effect of releasing lactic acid into the blood, and therefore acts as an alkali. This can be expected to have the effect of preventing lactic acidosis in the blood, which occurs due to the production of lactic acid after excessive drinking, and thus one of the causes of hangover. Potassium citrate is quickly absorbed through the gastrointestinal tract. The substances absorbed from the gastrointestinal tract are immediately introduced into the liver and hepatocytes. Citric acid is better ionized near the liver cells, which are acidic due to the production of lactic acid in a state of excessive drinking, and H + Captures HCO3 - It normalizes blood pH by increasing blood pH by releasing CO2. Meanwhile, the CO2 generated in this process diffuses smoothly into the inner mitochondrial membrane due to its gas-permeable nature. Potassium citrate plays a role in directly supplying carbon dioxide and potassium to liver cells. In order to change nitrogen into urea in the urea cycle, NH in the mitochondria 4+ Carbon dioxide must react to form carbamoyl phosphate. Since the TCA cycle does not operate smoothly when drinking excessively, less CO2 is produced, so it can be predicted that a smooth supply of external CO2 is necessary for activating the urea cycle. At this time, the citric acid of potassium citrate is H +It reacts with water to form water and carbon dioxide. Carbon dioxide enters the cell and temporarily forms hypercapnia. This allows carbon dioxide to pass smoothly through the inner mitochondrial membrane and supply the carbon dioxide needed to form carbamoyl phosphate. Therefore, potassium citrate activates the metabolic process in which L-ornithine captures ammonia radicals in the mitochondria and is converted to citrulline. As a result, it is expected to have the effect of preventing the accumulation of ammonia radicals in liver cells, normalizing the mitochondria, and facilitating the removal of acetaldehyde.
[0046] Potassium is excreted in large quantities due to drinking. Because potassium in the extracellular fluid decreases, extracellular shift occurs, so cells bring potassium into the cell through Na / K ATPase, and the cell uses more ATP. In order for liver cells to respond to ROS generated during alcohol metabolism, K + However, when alcohol is consumed, potassium is excreted, so we end up in a situation where we are deficient.
[0047] In liver cells that have more trouble responding to ROS due to potassium deficiency, potassium supplementation can be used to activate the liver cells. The above potassium citrate is absorbed faster through the gastrointestinal tract than other potassium-containing preparations, so it is absorbed within a few hours and reaches the liver cells quickly, directly supplying potassium to the liver cells. It is expected that the supply of potassium will reduce ROS generated in mitochondria, thereby lowering the inflammatory response caused by ROS in the future. Therefore, it is expected to contribute to alleviating hangover after drinking. On the other hand, when the pH is low, H + Due to the nature of citric acid to react with H in the stomach +It is also expected to play a role in raising the pH of the stomach by reacting with alcohol. When drinking, excessive gastric acid is secreted, and by neutralizing this, it is expected to alleviate symptoms that appear immediately after drinking, such as heartburn, nausea, and vomiting.
[0048] The present inventor is K + By directly introducing K into the liver cells + Potassium citrate was incorporated as an active ingredient to prevent depletion. Meanwhile, citrate is also expected to contribute to the activation of the urea cycle by supplying carbon dioxide, which, together with L-ornithine, contributes to its effects. In particular, potassium citrate is absorbed through the gastrointestinal tract faster than other ingredients, rapidly reaching liver cells and thus significantly contributing to alcohol decomposition.
[0049] The above “cabbage powder” is an ingredient for protecting the stomach when drinking alcohol, and can be obtained by slicing cabbage, drying it to remove moisture, and then grinding it. The cabbage powder is a natural anti-ulcer food and contains ingredients that protect and strengthen the gastric mucosa, and is effective in preventing cancers such as gastric cancer and colon cancer. In addition, it is rich in dietary fiber and low in calories, so it is effective in dieting, preventing constipation, and preventing skin aging. The inventors of the present invention have configured the cabbage powder as an active ingredient for the purpose of exerting the effect of inhibiting alcohol absorption and the antioxidant / anti-inflammatory effect and the acetaldehyde decomposition promotion effect of dietary fiber in addition to the effect of protecting the gastric mucosa. Furthermore, sulforaphane contained in the cabbage powder has excellent antioxidant effects, cell stress reduction effects, and inflammation reduction effects when oxidative stress is induced in cells. Furthermore, sulforaphane is contained in the salivary glands and activates hsALDH, an isoform of ALDH that is normally inactive, thereby inducing ALDH to decompose acetaldehyde. Therefore, it is helpful for people with ALDH gene mutations who have difficulty decomposing acetaldehyde. The prevalence of ALDH mutations in Koreans is estimated to be around 30%. Accordingly, it is effective in reducing oxidative stress on liver cells caused by ROS generated during excessive alcohol consumption, promoting acetaldehyde decomposition, and consequently reducing inflammation.
[0050] Alcohol is transported to the large intestine through the bloodstream, so that the blood alcohol concentration becomes equal to the alcohol concentration in the large intestine. In other words, the concentration in the large intestine reaches its peak between 30 and 90 minutes after drinking, when the blood alcohol concentration is at its peak. In the large intestine, alcohol-acetaldehyde metabolism occurs through the ADH of E. coli, producing acetaldehyde. Since the activity of ALDH in the large intestine's flora is very low compared to ADH, the concentration of acetaldehyde in the large intestine is highest in the body. Generally, it takes more than 9 hours for ingested food to reach the large intestine, and acetaldehyde is produced before the lactic acid bacteria are delivered to the large intestine with food. Therefore, it is expected that the lactic acid bacteria consumed before drinking will not have a significant effect on the elimination of acetaldehyde on the day of drinking. Therefore, cabbage is useful because it contains a lot of insoluble dietary fiber that, as dietary fiber, activates overall intestinal movement, increases the speed of the intestines, increases the speed of defecation, reduces the absorption of already formed acetaldehyde into the blood, and promotes intestinal movement. In particular, heat-treated cabbage powder is effective in treating hepatitis inflammation by reducing the expression of inflammatory mediators iNOS and COX-2 and proinflammatory cytokine IL-1β involved in the acute inflammatory response accompanying liver damage. The cabbage powder used in the present invention is heat-treated at approximately 121°C. Furthermore, MMSC (s-methylmethionine sulfonium chloride), a representative anti-inflammatory ulcer factor in cabbage, promotes the production of prostaglandin, a local hormone secreted in the gastric mucosa, and prostaglandin secreted into the gastric cavity provides the gastric mucosa with the ability to defend against gastric acid or other aggressive factors.
[0051] As described above, the cabbage powder used in the present invention is not juice obtained from freeze-dried cabbage, but rather heat-treated cabbage powder containing insoluble dietary fiber. Therefore, in addition to the cabbage's effect of suppressing acute gastritis, it can also exert the effects of insoluble dietary fiber, which absorbs water to increase stool volume and shorten intestinal transit time, thereby preventing constipation and enteritis. Furthermore, since the lactic acid bacteria used in this patented material are mixed with dietary fiber, initial alcohol decomposition through the lactic acid bacteria's ADH can also be expected. Therefore, rather than exerting an anti-inflammatory effect in the stomach, alcohol is absorbed in the small intestine, the primary site of alcohol absorption, thereby slowing alcohol absorption. Furthermore, the lactic acid bacteria mixed with the cabbage can be expected to decompose alcohol and promote excretion. Furthermore, it can be expected to be useful in alleviating hangovers by reducing ROS generated in the liver and promoting acetaldehyde decomposition, thereby alleviating inflammatory responses.
[0052] Almost all of the aforementioned "Bifidobacteria" and "Lactobacillus" strains possess the ability to break down alcohol and / or acetaldehyde. Therefore, when administered together with cabbage, a dietary fiber, they can be expected to help break down alcohol absorbed by the cabbage, thus facilitating alcohol decomposition in the early stages of drinking.
[0053] The above "Bifidobacteria" are a genus of Gram-positive, non-motile, and often anaerobic bacteria. They are found in the gastrointestinal tract, vagina, and mouth of mammals. Bifidobacteria are one of the major genera of bacteria that make up the colon flora in mammals. Bifidobacterium organisms are commercially available and sold as probiotics for human consumption. For example, Dr. Mercola ® Complete Probiotics capsules by contain 70 billion organisms, including three species of bifidobacteria. Other commercial sources of bifidobacteria are also available (e.g., Align® Bifantis ® Any species of bifidobacterium that may be used in the present invention may be suitable, as strains of this genus are known to live and function in the human digestive tract and are known to be safe for human consumption. Such strains used in the methods and compositions of the present invention include, without limitation, B. infantis, B. breve, B. adolescentis, B. animalis, B. pseudolongum, B. thermophilum, B. indicum, B. asteroids, B. lactis, B. longum, B. coagulans, B. dentium, B. infantis, B. animalis ssp. lactis, and B. bifidum.
[0054] The above “Lactobacillus” is a Gram-positive facultative anaerobic or microaerophilic rod-shaped bacterium. This genus constitutes a major part of the group of bacteria (lactic acid bacteria) that convert lactose and other sugars into lactic acid. They are found in the human gastrointestinal tract and vagina. Some strains of Lactobacillus have potential therapeutic properties, including anti-inflammatory and anticancer abilities. Lactobacillus also promotes the healing of gastric ulcers. There are various commercial sources of Lactobacillus (e.g., Health & Wellness 30-Capsules or Digestive Health 30-Capsules sold by Culturelle). ® , Cromwell, Connecticut; Nutrition Now ® Pro-Biotics Acidophilus from GNC; FoodScience ®Any species of Lactobacillus that may be used in the present invention may be suitable, as strains of this genus are known to live and function in the human digestive tract and are known to be safe for human consumption. Such strains used in the methods and compositions of the present invention include, but are not limited to, L. acidophilus (e.g., L. acidophilus DDS-1, L. acidophilus LA-5, L. acidophilus NCFM), L. bulgaricus, L. jugurti, L. helveticus, L. salivarius, L. casei, L. plantarum, L. salivarius, L. rhamnosus (e.g., L. rhamnosus A), L. paracasei, L. lactis, L. infantis, and L. brevis.
[0055] The aforementioned "Bifidobacteria" and "Lactobacillus" are representative genera used as probiotic lactic acid bacteria. The strength of the acid, the duration of exposure to acid, and the type of strain are major factors affecting the survival of lactic acid bacteria in the stomach. Among them, the aforementioned "Bifidobacteria" and "Lactobacillus" are widely used in lactic acid bacteria products because they survive in acidic environments. In particular, L. acidophilus and B. longum survive better in the stomach and adhere better to the gastric mucosa.
[0056] Alcohol is primarily absorbed in the small intestine and causes barrier damage. Lactic acid bacteria improve barrier damage and reduce endotoxin absorption, minimizing liver damage. Oxidative stress caused by alcohol in the intestine disrupts the tight junctions of intestinal epithelial cells, increasing intestinal permeability. Acetaldehyde also increases intestinal permeability by destroying microtubules within intestinal epithelial cells. Increased intestinal permeability allows endotoxins present in the cell walls of Gram-negative bacteria in the intestine to enter the bloodstream, promoting the secretion of inflammatory cytokines such as TNF-α, IL-1, and IL-6, leading to liver cell damage (https: / / koreascience.kr / article / JAKO201409649928775.pdf). These inflammatory cytokines are also found in alcohol metabolism, suggesting that increased intestinal permeability due to drinking may exacerbate liver damage. Lactic acid produced by lactic acid bacteria promotes the proliferation of intestinal stem cells and regenerates intestinal mucosal epithelial cells. The 'Bifidobacteria' and 'Lactobacillus' used as ingredients in this patent have excellent ability to withstand gastric acid, so it is expected to have the effect of producing lactic acid in the small intestine, proliferating intestinal stem cells, and recovering the intestinal mucosa damaged by drinking. Therefore, it is expected to contribute to reducing liver damage caused by excessive drinking and alleviating hangovers. It takes time for food to reach the large intestine, and acetaldehyde is produced in the large intestine immediately after drinking and reaches the maximum concentration before the food reaches the large intestine, and the degree of alcohol decomposition in the early stages of drinking determines the degree of hangover the next day. Therefore, rather than focusing on the contribution of lactic acid bacteria to recovering from small intestine damage, the lactic acid bacteria used in the present invention use 'Lactobacillus' that is highly resistant to gastric acid and 'Bifidobacteria' that are abundant in the large intestine. Accordingly, the combination of the above “Bifidobacterium” and “Lactobacillus” lactic acid bacteria can reduce irritation of the stomach caused by alcohol, and at the same time alleviate erosive gastritis, heartburn, and nausea.Furthermore, since the proliferation of the lactic acid bacteria is promoted in the presence of dietary fiber, it exhibits a synergistic effect with cabbage powder, such as an effect of healing gastric ulcers.
[0057] In one embodiment, in the food composition, the L-ornithine is contained in an amount of 15 to 30 wt% based on the total weight of the composition, the potassium citrate is contained in an amount of 2 to 12 wt% based on the total weight of the composition, the cabbage powder is contained in an amount of 30 to 50 wt% based on the total weight of the composition, and the lactic acid bacteria is contained in an amount of 2 to 14 wt% based on the total weight of the composition.
[0058] More specifically, the L-ornithine is contained in an amount of 15 wt% or more, 16 wt% or more, 17 wt% or more, 18 wt% or more, 19 wt% or more, 20 wt% or more, 21 wt% or more, 22 wt% or more, 23 wt% or more; 30 wt% or less, 29 wt% or less, 28 wt% or less, 27 wt% or less, 26 wt% or less, 25 wt% or less, 24 wt% or less, or 23 wt% or less based on the total weight of the composition.
[0059] In one embodiment, the potassium citrate is contained in an amount of 2 to 12 wt% based on the total weight of the composition. More specifically, the potassium citrate is contained in an amount of at least 2 wt%, at least 3 wt%, at least 4 wt%, at least 5 wt%, at least 6 wt%, at least 6.7 wt%, or at most 12 wt%, at most 11 wt%, at most 10 wt%, at most 9 wt%, at most 8 wt%, at most 7 wt%, at most 6.7 wt% based on the total weight of the composition.
[0060] More specifically, the cabbage powder is contained in an amount of 30 wt% or more, 31 wt% or more, 32 wt% or more, 33 wt% or more, 34 wt% or more, 35 wt% or more, 36 wt% or more, 37 wt% or more, 38 wt% or more, 39 wt% or more, 40 wt% or more; 50 wt% or less, 49 wt% or less, 48 wt% or less, 47 wt% or less, 46 wt% or less, 45 wt% or less, 44 wt% or less, 43 wt% or less, 42 wt% or less, 41 wt% or less, 40 wt% or less, based on the total weight of the composition.
[0061] More specifically, the lactic acid bacteria are contained in an amount of 2 wt% or more, 3 wt% or more, 4 wt% or more, 5 wt% or more, 6 wt% or more, 7 wt% or more; 14 wt% or less, 13 wt% or less, 12 wt% or less, 11 wt% or less, 10 wt% or less, 9 wt% or less, 8 wt% or less, 7 wt% or less, or 6 wt% or less based on the total weight of the composition.
[0062] In one embodiment, in the food composition, the L-ornithine, potassium citrate, cabbage powder, and lactic acid bacteria are contained in a ratio of 2 to 5:1 to 2:4 to 10:1 to 2, or a ratio of 3 to 4:1 to 2:5 to 8:1 to 2, or a ratio of 3 to 4:1 to 2:5 to 7:1 to 2, based on weight.
[0063] In one embodiment, the food composition further comprises water parsley powder.
[0064] The above "water parsley (Oenanthe javanica) powder" contains persicarin, which activates enzymes involved in alcohol metabolism. Water parsley is a perennial herb of the Apiaceae family, native to Korea and widely distributed in subarctic to tropical regions, including China and Japan, where it is cultivated for food.
[0065] The above water parsley powder is contained in an amount of 3 to 13 wt% based on the total weight of the composition. More specifically, the water parsley powder is contained in an amount of 3 wt% or more, 4 wt% or more, 5 wt% or more, 6 wt% or more, 7 wt% or more, 8 wt% or more, 8.14 wt% or more; 13 wt% or less, 12 wt% or less, 11 wt% or less, 10 wt% or less, 9 wt% or less, 8.14 wt% or less based on the total weight of the composition.
[0066] In one embodiment, the food composition further comprises a turmeric extract.
[0067] The above "turmeric extract" is known to have pharmacological effects such as promoting bile secretion, uterine stimulation, lowering blood pressure, and analgesic effects. It has the effect of inhibiting the growth of Staphylococcus aureus and fungi, and has been proven to have an effect of reducing hyperlipidemia [Korean Compendium of Materia Medica, by Deok-gyun Ahn]. Turmeric (Curcuma longa L) is the rhizome of the perennial herb Curcuma longa. Turmeric is mainly cultivated in subtropical regions with abundant rainfall from southern China to Southeast Asia. It also grows wild in forested areas of South and Southeast Asia. Turmeric contains curcumin and essential oil components such as turmerone, zingerene, phellandrene, cineole, sabinene, bornol, and dehydroturmerone. The curcumin is a type of polyphenol and exerts an effect of protecting the liver and suppressing systemic inflammatory responses through anti-inflammatory and antioxidant effects. More specifically, it exerts an anti-inflammatory effect by altering NF-κB signaling and participating in the production of inflammatory cytokines (interleukin, phospholipase A2 production inhibition COX2, COX5).
[0068] The turmeric extract is contained in an amount of 3 to 13 wt% based on the total weight of the composition. More specifically, the turmeric extract is contained in an amount of 3 wt% or more, 4 wt% or more, 5 wt% or more, 6 wt% or more, 7 wt% or more, 8 wt% or more; 13 wt% or less, 12 wt% or less, 11 wt% or less, 10 wt% or less, 9 wt% or less, or 8 wt% or less based on the total weight of the composition.
[0069] According to one embodiment of the present disclosure, the composition is a health functional food composition. In one embodiment, the food composition may be incorporated into a health functional food product in the form of a powder, granule, pill, tablet, capsule, or beverage. The manufacturing method may include, but is not limited to, baking or far-infrared ray.
[0070] The above “health functional food” refers to a food manufactured or processed for the purpose of health supplementation by using specific ingredients as raw materials or by extracting, concentrating, refining, mixing, etc. specific ingredients contained in raw materials, and means a food designed and processed so that the above ingredients can sufficiently exert biological defense and other biological regulation functions on the body, and means a food that can perform functions related to disease prevention, improvement, or health recovery.
[0071] There is no particular limitation on the types of health functional foods in which the extracts according to the present disclosure can be used. For example, they include ramen, other noodles, beverages, tea, drinks, alcoholic beverages, various soups, meat, sausage, bread, chocolate, candy, confectionery, pizza, gum, dairy products including ice cream, or vitamin complexes. In addition, the health functional foods include powder, granules, tablets, capsules, or beverages, and preferably include beverages. In addition, when the extracts according to the present disclosure are used as health functional foods, they can be added as is or used together with other foods or food ingredients, which can be selected and used appropriately as needed. In addition to the extracts according to the present disclosure, other appropriate auxiliary ingredients and known additives that can be conventionally included in health functional foods can be mixed according to the selection of a person skilled in the art.
[0072] Method for manufacturing a food composition for relieving hangovers and improving liver function
[0073] In another aspect, the present invention provides a method for producing a food composition for relieving hangovers and improving liver function, comprising the steps of: mixing a powdered raw material including L-ornithine, potassium citrate, cabbage powder, and at least one lactic acid bacterium selected from the group consisting of bifidobacteria and lactobacillus with water to produce a mixture; forming the mixture into a pill to produce a pill precursor; forming the pill precursor into a smooth surface; and drying the pill precursor, the surface of which is formed into a smooth surface, to produce a pill.
[0074] In another aspect, the present invention provides a method for producing a food composition for relieving hangovers and improving liver function, comprising the steps of: extracting and drying cabbage to produce cabbage powder; and mixing L-ornithine, potassium citrate, and one or more lactic acid bacteria selected from the group consisting of bifidobacteria and lactobacillus with the cabbage powder.
[0075] In a manufacturing method according to one embodiment of the present invention, the extraction may be performed by grinding the freeze-dried raw material, adding distilled water, and extracting at 75 to 85°C for 2 to 4 hours, and preferably, adding distilled water to the freeze-dried raw material and extracting at 80°C for 3 hours three times.
[0076] According to one embodiment of the present invention, the step of preparing the powder may be performed before the step of mixing, may be performed after the step of mixing, or may be performed simultaneously.
[0077] In one embodiment, the powder raw material and water are mixed in a weight ratio of 1 to 3:1. More specifically, they are mixed in a weight ratio of 7:3.
[0078] In one embodiment, the diameter of the ring precursor is 4 to 6 mm. More specifically, it is 5 mm.
[0079] In one embodiment, the method further comprises packaging the ring in a four-sided packaging container having a square or rectangular shape.
[0080] In one embodiment, the drying is performed at 35°C to 37°C for 60 to 72 hours.
[0081] In one embodiment, the manufacturing method includes the steps of mixing each powder raw material; kneading the mixed raw material and water in a kneader; forming the dough into a pill shape by putting the dough in a pill making machine; forming the formed pill into a molding machine and forming the surface of the pill; drying the formed pill in a dryer; putting the dried pill into a pill sorting machine and sorting out defective pills; and wrapping the sorted pill in a four-sided packaging bag; moving the wrapped semi-finished product to a packaging room and packaging it in a separate case and a box for shipment; and moving the box-packed finished product to a shipping waiting area.
[0082] {Example}
[0083] Hereinafter, the present disclosure will be described in detail by way of examples. However, the following examples are merely examples to aid in the overall understanding of the present disclosure, and the contents of the present disclosure are not limited to the following examples.
[0084] <Manufacturing Example 1> Manufacturing of a food composition for relieving hangovers and improving liver function
[0085] According to the compositions described in Tables 1 and 2 below, food compositions for relieving hangovers and improving liver function according to Examples 1 to 4 of the present invention were prepared.
[0086] [Table 1]
[0087]
[0088] [Table 2]
[0089]
[0090] [Table 3]
[0091]
[0092] [Table 4]
[0093]
[0094] <Reference Example 1> Preparation of a composition according to a comparative example
[0095] Compositions according to Comparative Examples 1 to 4 were prepared in the same manner as in Example 1, except that they did not contain L-ornithine, did not contain potassium citrate, did not contain cabbage powder, and did not contain lactic acid bacteria.
[0096] <Experimental Example 1> Evaluation of suppression of alcohol concentration increase in the body
[0097] Ten men and women, aged 30-40 years and weighing 65-75 kg, were selected as subjects for the experiment, and the amount of alcohol consumed was 400 ml (alcohol content 19.5%). The initial alcohol concentration was measured 30 minutes after drinking, and then 5 g of the health functional food manufactured for each example and comparative example was consumed. The alcohol concentration (unit: mg / L) was measured using a breathalyzer 90 minutes after drinking. The difference in alcohol concentration 30 minutes and 90 minutes after drinking is shown in Table 5.
[0098] [Table 5]
[0099]
[0100] <Experimental Example 2> Alcohol Hangover Severity Scale (AHSS) Evaluation
[0101] Ten men and women, aged 30-50 years and weighing 65-75 kg, participated in the study. They consumed 400 ml of alcohol (19.5% ABV). Participants were asked to rate their symptoms before and the day after drinking (0 = none, 10 = extreme). The results are presented in Table 6 (after:before).
[0102] [Table 6]
[0103]
[0104] From the above Table 6, it can be seen that the severity of alcohol hangover is improved after taking the health functional food according to the present invention.
[0105] <Formulation Example 1> Preparation of pills
[0106] A pill was prepared by a conventional method according to the composition described in Table 7 below.
[0107] [Table 7]
[0108]
[0109] <Formulation Example 2> Preparation of pills
[0110] A pill was prepared by a conventional method according to the composition described in Table 8 below.
[0111] [Table 8]
[0112]
[0113] <Formulation Example 9> Preparation of pills
[0114] A health functional drink was manufactured using a conventional method according to the composition described in Table 9 below.
[0115] [Table 9]
[0116]
[0117] While the present invention has been described with reference to the preferred embodiments mentioned above, various modifications and variations are possible without departing from the spirit and scope of the invention. Accordingly, the appended claims are intended to encompass such modifications and variations as fall within the spirit of the invention.
Claims
1. L-ornithine, potassium citrate, cabbage powder, and one or more lactic acid bacteria selected from the group consisting of bifidobacteria and lactobacillus; A food composition for relieving hangovers and improving liver function, comprising:
2. In paragraph 1, The above L-ornithine is contained in an amount of 15 to 30 wt% based on the total weight of the composition, The above potassium citrate is contained in an amount of 2 to 12 wt% based on the total weight of the composition, The above cabbage powder is contained in an amount of 30 to 50 wt% based on the total weight of the composition, A food composition, wherein the lactic acid bacteria are contained in an amount of 2 to 12% by weight based on the total weight of the composition.
3. A step of preparing a mixture by mixing powdered raw materials including L-ornithine, potassium citrate, cabbage powder, and one or more lactic acid bacteria selected from the group consisting of bifidobacteria and lactobacillus with water; A step of manufacturing a ring precursor by refining the above mixture; A step of forming the above ring precursor to form a smooth surface; and A step of manufacturing a ring by drying the ring precursor having a smooth surface; A method for producing a food composition for relieving hangovers and improving liver function, comprising:
Citation Information
Patent Citations
Alcoholic metabolic beverage included fermented solution of vegetable extract and process thereof
KR100140057B1
Flexible board and printed circuit board comprising the same
KR1020200118536A
Compositions for preventing and relieving hangover & liver damage which occur due to alcohol consumption
US20190320688A1
